Malaria: Focus on Prevention and Get the African Privileged Engaged

by Dr. K Amponsah-Manager I have written on malaria in the past. Since then, much has changed and nothing has changed. There are more than 400 million cases of malaria annually. Most of malaria infections and deaths occur in Sub-Saharan African where the most vulnerable are infants, pregnant mothers and seniors. In fact, it is… Continue reading Malaria: Focus on Prevention and Get the African Privileged Engaged

Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals

The United States Food and Drug Administration (FDA) has granted Glenmark Pharmaceuticals final approval to sell a generic version of GlaxoSmithKline (GSK) malaria drug Malarone. In April 2010, Glenmark settled a patent litigation with GlaxoSmithKline over atovaquone and proguanil hydrochloride 250 milligram/100mg tablets–the generic version of Malarone. The Indian company can sell the generic tablets… Continue reading Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals

African governments urged to allocate more resources to fight malaria

The African Media and Malaria Research Network (AMMREN), an advocacy network of scientists and journalists, has urged African governments and policy makers to allocate more resources to the prevention and control of malaria. “The success of various malaria initiatives depend on political will, dedication of health workers, and above all, the willingness of the individual… Continue reading African governments urged to allocate more resources to fight malaria

Eradicating malaria in Sub-saharan Africa, Yes We Can

As promised last week, this is a response to the recommendations by the international team of experts on what governments and organizations should be doing with malaria.